Option chain shows key data for 60 Degrees's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for 60 Degrees.

60 Degrees (NASDAQ:SXTP) Stock, Option Chain

60 Degrees

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

Nasdaq index

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

BJDX

CVRX

CYCU

SXTP

TLRY

Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings

Driving Down Costs

NAOV

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

Wall Street subway sign

BACK

BHAT

SLXN

ZKIN

US Stocks Mixed; General Dynamics Earnings Top Views

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. - Warrant

Health Care

Press Releases

60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

RedChip Launches RedChat: Revolutionary AI Chatbot for Small-Cap Stock Analysis

Financing

60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

General

Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split

60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

60 Degrees Pharmaceuticals Announces 2024 Annual Results

Legal

Sixty Degrees Pharmaceuticals Announces Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention with Yale School of Medicine and Yale School of Public Health

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

BFRG

CNTM

FTHM

GRRR

OSTX

SXTPW

Adial Pharmaceuticals, Inc - Common Stock

Adial Pharmaceuticals

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Akanda

Artelo Biosciences

Athira Pharma

Aytu BioPharma

Biofrontera

CNS Pharma

China Pharma Holding

Citius Pharmaceuticals, Inc. - Common Stock

Citius Pharmaceuticals

Enveric Biosciences

Evoke Pharma

Eyenovia

Gelteq

Impact BioMedical

Jaguar Health

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lyra Therapeutics

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

ProPhase Labs

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

SenesTech

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

Titan Pharmaceuticals, Inc. - Common Stock

Titan Pharma

Ascendiant Capital

Comments

60 Degrees

60 Degrees (SXTP) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga